AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H590-H598, 2006. First published September 30, 2005; doi:10.1152/ajpheart.00379.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/2/H590    most recent
00379.2005v2
00379.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higuchi, Y.
Right arrow Articles by Feldman, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higuchi, Y.
Right arrow Articles by Feldman, A. M.

Cardioprotection afforded by NF-{kappa}B ablation is associated with activation of Akt in mice overexpressing TNF-{alpha}

Yoshihiro Higuchi,1,* Tung O. Chan,1,* Maria A. Brown,2 Jin Zhang,1 Brent R. DeGeorge, Jr.,1 Hajime Funakoshi,1 Gregory Gibson,3 Charles F. McTiernan,3 Toru Kubota,4 W. Keith Jones,2 and Arthur M. Feldman1

1Center For Translational Medicine, Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania; 2Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, Ohio; 3Cardiovascular Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and 4Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Submitted 18 April 2005 ; accepted in final form 15 September 2005

When selectively overexpressed in mouse heart, TNF-{alpha} effects the development of a cardiomyopathy that closely mimics that seen in human failing hearts. It has been suggested that two intracellular signaling pathways, the Akt protein kinase and the NF-{kappa}B transcription factor, mediated TNF-{alpha} signaling. The present experiments assessed the effects of TNF-{alpha} overexpression on these two target proteins in vivo. We measured cardiac Akt kinase phosphorylation and NF-{kappa}B activity in mice overexpressing TNF-{alpha} (TNF1.6). Both basal and insulin-stimulated Akt phosphorylation were reduced by almost 70% by TNF-{alpha} overexpression. By contrast, NF-{kappa}B was robustly activated. These effects were absent when TNF-{alpha} receptor 1 (TNFR1) was selectively ablated. Cardiomyocyte-specific overexpression of the dominant-negative inhibitory {kappa}B protein transgene and subsequent inhibition of NF-{kappa}B activity attenuated the effects of TNF-{alpha} on Akt phosphorylation. NF-{kappa}B inhibition also significantly improved fractional shortening and diminished ventricular hypertrophy and survival without affecting infiltrative inflammation or cytokine expression. Thus, while overexpression of TNF-{alpha} effected a marked Akt inhibition and NF-{kappa}B activation in mouse hearts, inhibition of NF-{kappa}B offered salutary benefits mediated at least in part through activation of Akt.

tumor necrosis factor-{alpha}; insulin signaling; TNF-{alpha} receptor; protein kinase B; dominant-negative inhibitory {kappa}B protein transgene



Address for reprint requests and other correspondence: A. M. Feldman, Dept. of Medicine, Jefferson Medical College, 1025 Walnut St., Philadelphia, PA 19107 (e-mail: arthur.feldman{at}jefferson.edu)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
P. J.H. Smeets, B. E.J. Teunissen, P. H.M. Willemsen, F. A. van Nieuwenhoven, A. E. Brouns, B. J.A. Janssen, J. P.M. Cleutjens, B. Staels, G. J. van der Vusse, and M. van Bilsen
Cardiac hypertrophy is enhanced in PPAR{alpha}-/- mice in response to chronic pressure overload
Cardiovasc Res, April 1, 2008; 78(1): 79 - 89.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. A. Elmarakby, J. E. Quigley, J. J. Olearczyk, A. Sridhar, A. K. Cook, E. W. Inscho, D. M. Pollock, and J. D. Imig
Chemokine Receptor 2b Inhibition Provides Renal Protection in Angiotensin II Salt Hypertension
Hypertension, December 1, 2007; 50(6): 1069 - 1076.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Funakoshi, T. O. Chan, J. C. Good, J. R. Libonati, J. Piuhola, X. Chen, S. M. MacDonnell, L. L. Lee, D. E. Herrmann, J. Zhang, et al.
Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function
Circulation, November 21, 2006; 114(21): 2240 - 2250.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Hilfiker-Kleiner, U. Landmesser, and H. Drexler
Molecular Mechanisms in Heart Failure: Focus on Cardiac Hypertrophy, Inflammation, Angiogenesis, and Apoptosis
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A56 - A66.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.